Joseph J Larosa insider trades: Regeneron Pharmaceuticals (REGN) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Joseph reports to the SEC
Open-market buys and sales
17 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | REGN | ↓ Sell | 4,466 | $965.49 | $4.3M | Direct | Nov 4, 2026 (2d) |
| Jul 11, 2024 | REGN | ↓ Sell | 1,866 | $1088.95 | $2.0M | Direct | Jul 12, 2024 (1d) |
| May 21, 2024 | REGN | ↓ Sell | 1,865 | $994.90 | $1.9M | Direct | May 22, 2024 (1d) |
| Feb 26, 2024 | REGN | ↓ Sell | 1,000 | $990.00 | $990K | Direct | Feb 28, 2024 (2d) |
| Feb 22, 2024 | REGN | ↓ Sell | 1,000 | $967.65 | $968K | Direct | Feb 26, 2024 (4d) |
| Feb 7, 2024 | REGN | ↓ Sell | 1,000 | $950.00 | $950K | Direct | Feb 9, 2024 (2d) |
| Apr 7, 2022 | REGN | ↓ Sell | 5,114 | $721.10 | $3.7M | Direct | Apr 11, 2022 (4d) |
| Apr 1, 2022 | REGN | ↓ Sell | 5,114 | $690.73 | $3.5M | Direct | Apr 4, 2022 (3d) |
| Aug 23, 2021 | REGN | ↓ Sell | 3,425 | $661.84 | $2.3M | Direct | Aug 24, 2021 (1d) |
| Jul 6, 2021 | REGN | ↓ Sell | 3,398 | $580.00 | $2.0M | Direct | Jul 7, 2021 (1d) |
| Aug 31, 2020 | REGN | ↓ Sell | 4,672 | $615.04 | $2.9M | Direct | Aug 31, 2020 (0d) |
| May 15, 2020 | REGN | ↓ Sell | 8,380 | $572.00 | $4.8M | Direct | May 15, 2020 (0d) |
| Apr 20, 2020 | REGN | ↓ Sell | 5,789 | $562.31 | $3.3M | Direct | Apr 20, 2020 (0d) |
| Apr 20, 2020 | REGN | ↓ Sell | 1,778 | $570.30 | $1.0M | Direct | Apr 20, 2020 (0d) |
| Apr 15, 2020 | REGN | ↓ Sell | 2,262 | $518.21 | $1.2M | Direct | Apr 16, 2020 (1d) |
| Apr 2, 2020 | REGN | ↓ Sell | 6,797 | $489.98 | $3.3M | Direct | Apr 3, 2020 (1d) |
| Mar 16, 2015 | REGN | ↓ Sell | 18,311 | $450.00 | $8.2M | Direct | Mar 17, 2015 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other REGN insiders
Open-market trades in the last 12 months
About Joseph J Larosa's insider trades
Joseph J Larosa is EVP General Counsel and Secret at Regeneron Pharmaceuticals (REGN). Since Mar 16, 2015, Joseph has reported no open-market purchases and 17 sales worth $47.2M on SEC Form 4. In the last 12 months: 1 sale ($4.3M).
Their filings also include shares withheld for taxes (22 filings), option exercises (19 filings), grants and awards (16 filings), gifts (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every REGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.